Loading...
XSHG
688639
, Last price  
Name

Anhui Huaheng Biotechnology Co Ltd

Chart & performance

D1W1MN
XSHG:688639 chart
P/E
—
P/S
—
EPS
1.22
Vol. 1Y
—
Shs. 5Y
8.19%
Rev. 5Y
42.49%
Div Yld LY
—
Div Yld TTM
—
Revenues
2.86b
+31.40%
86,677,592173,400,448224,867,745253,471,874311,399,361382,545,425420,846,693491,310,784487,244,632954,096,0781,418,651,8821,938,268,1162,177,940,8382,861,841,123
Net income
132m
-30.13%
-3,797,35012,998,93322,985,45042,801,20661,793,61264,894,50475,506,659126,378,303121,100,230168,235,541320,029,453449,061,469189,518,896132,412,138
CFO
105m
-47.67%
041,206,60030,557,20035,269,80055,021,462105,690,03889,308,144181,476,547109,568,96595,702,545357,425,071304,277,793199,794,611104,546,671
Dividend
May 12, 20260.16 /sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Anhui Huaheng Biotechnology Co., Ltd. specializes in the research, manufacturing, and international distribution of amino acids and various organic acids. The company's product range encompasses L-alanine, DL-alanine, beta-alanine, and D-alanine, as well as L-aspartic, DL-aspartic, D-aspartic acids, and L-aspartate salt. Additionally, it provides an array of other amino acids and arbutin products. These ingredients are widely utilized in pharmaceuticals, healthcare goods, food and food additives, daily personal care items, and other diverse industrial applications. Founded in Hefei, China, in 2005, the company operated as Anhui Huaheng Biological Engineering Co., Ltd. until its name officially changed to Anhui Huaheng Biotechnology Co., Ltd. in November 2013.

Key people

Yi Fan
Finance Director, Deputy General Manager, Secretary of the Board, Director · since 2016
Henghua Guo
Chairman of the Board, General Manager · since 2013
Fanbao Meng
Deputy General Manager · since 2016
Siqing Tang
Deputy General Manager · since 2013
Dongzhu Zhang
Deputy General Manager, Director · since 2007
Hengping Guo
Director · since 2013
Yunzhong Shi
Director · since 2014
Xueli Zhang
Director · since 2013
Shimin Chen
Independent Director
Shuguang Zhang
Independent Director
IPO date
Apr 22, 2021
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT